about
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerLong-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort studyFrequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.Paget's disease of the nipple in a population based cohort.Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo.The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingThe Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort.Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancerMetastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?Impact of comorbidity on management and mortality in women diagnosed with breast cancer.Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.[A case report. FDG-PET in occult breast cancer].[Knee prosthesis surgery can be performed at regional hospitals]Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples.Analysis of Fhit expression in stages of breast cancer progression.Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression.Placental weight and mortality in premenopausal breast cancer by tumor characteristics.Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.Risk of subsequent invasive breast cancer after breast carcinoma in situTumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based StudyLong-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer SurgeryRisk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.Ductal carcinoma in situ of the breast from a population-defined cohort: an evaluation of new histopathological classification systemsDuctal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosisDuctal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosityMammographic casting-type calcifications is not a prognostic factor in unifocal small invasive breast cancer: a population-based retrospective cohort studyEffect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial
P50
Q28277288-39A723C5-AFBA-4791-8498-76F9341B30C9Q33758934-51A39FB0-F5FA-466D-9F7E-46F04EA57F18Q33892868-6F607120-5732-41EE-858F-EAA21443F3D8Q34196315-95DA8B99-4B2A-4C85-BC66-C8F62C69E35BQ34454213-7135A6EF-A85E-4372-971D-19B22A7F4517Q34493998-446E0F5E-966E-40A0-B175-D4CFA34ED95CQ34704867-4A1306E4-7E92-44A8-A8E8-CB75F0941E7EQ35012724-3FBAC727-65CA-42C7-BD1E-E37696031853Q35660389-E0AD8386-1E34-44D8-885E-7739B4677B0CQ35779345-40C0F018-F79C-476C-9E00-8CCEBCB6CBDFQ36922539-45F94D05-395C-47FF-A7C9-29DEE53E74F9Q37486514-801EC16E-14FD-48ED-A6EC-240A5282548DQ37670843-994B7569-69D1-47A0-9F09-41224EFDC214Q37712773-CBC226CF-FB84-457E-BF75-776EBD0EBC60Q38099586-90239561-94F2-4727-9D70-283ABD626C22Q38431296-0DEF2C7C-654C-4870-B023-052C93D86E46Q38843629-BFD51DDC-5EE7-43ED-8740-F3C59EF43019Q39201898-68555996-8D4F-43CA-97E4-8356CCEB2CB6Q39466624-19CF1415-06E6-4829-8B8E-EA54AA45961DQ41130119-C136BEC9-5F2C-4653-AA6A-E9460274DDA4Q41130424-7B35988F-F669-4CEF-A1F8-20630594F8E8Q43907339-D1C6454C-F99E-4043-A62D-C914D1CCDE2FQ44351259-577BC48F-2B02-4BCA-8917-D4DBC5B7FF76Q44749651-870E63F9-75EB-4368-ACBC-3EAE28DA2882Q45152218-58D3EA66-451E-4BDB-A212-79EDCED0B121Q45404311-9F9143ED-DECA-45DD-8DED-F167DC6DC672Q46049235-39317D89-B621-43A4-B272-CEB8C4963304Q46201216-25A6E507-A3E8-45A2-BFFE-D6198B0B7E49Q46660446-A5FE5413-8458-4ED5-9409-C6D66CFBE952Q47272660-D712ABE1-5988-4FC3-BE18-A95FBAC7B17EQ53081580-5373AB2C-F489-4EFE-A40C-3C9744C0F635Q58834113-F51C32A4-EB0F-43EC-8EFC-71420B9F5B49Q59265015-799F4A8B-DBFC-4B66-B5B0-5C57BE4B78CDQ64066015-D47FEB6D-116E-44C1-9246-A010E59150E1Q64977504-83336A2F-66FD-4942-821E-864042843D38Q73038081-AB4D1A80-618B-41D1-AF40-8A6C8E8071AEQ74568965-E6B260EA-68D9-4471-8DB2-D06245235751Q81680858-6353E78A-C9D9-4B26-B8B9-CE30BA6D1272Q84578136-D6FBF137-ABC3-477C-9604-3455BD5243AEQ85774315-32FEAD02-6A5D-451F-9A22-04C949CA465F
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Fredrik Wärnberg
@ast
Fredrik Wärnberg
@en
Fredrik Wärnberg
@es
Fredrik Wärnberg
@nl
Fredrik Wärnberg
@sl
type
label
Fredrik Wärnberg
@ast
Fredrik Wärnberg
@en
Fredrik Wärnberg
@es
Fredrik Wärnberg
@nl
Fredrik Wärnberg
@sl
prefLabel
Fredrik Wärnberg
@ast
Fredrik Wärnberg
@en
Fredrik Wärnberg
@es
Fredrik Wärnberg
@nl
Fredrik Wärnberg
@sl
P214
P106
P21
P213
0000 0000 5597 4954
P214
P31
P496
0000-0002-0130-7296
P735
P7859
viaf-84807409